期刊
FUTURE MICROBIOLOGY
卷 4, 期 5, 页码 597-614出版社
FUTURE MEDICINE LTD
DOI: 10.2217/FMB.09.20
关键词
antitubercular agent; drug development; drug resistance mechanism; mycobacteria; tuberculosis
类别
资金
- EC-VI Framework [LSHP-CT-2005-018923]
TB is still a global health problem. The selection and spread of multidrug-resistant and extensively drug-resistant Mycobocterium tuberculosis strains represents a threat for global TB control. The reappearance of TB has driven an increased interest in understanding the mechanisms of drug action and drug resistance, which could provide a significant contribution in the development of new antimicrobials. In this article, the authors describe the mode of action and the resistance mechanisms of the principal first- and second-line antitubercular agents, namely isoniazid, ethionamide, ethambutol, D-Cycloserine, rifamycins, fluoroquinolones, streptomycin, linezolid and pyrazinamide. A brief outline of the seven drugs in clinical development is reported, showing how the development of new TB drugs is still required.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据